Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Major research hospitals such as Montefiore in New York now use cannabis for treating cancer and HIV, as well as make new studies.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

The Joint Blog

JANUARY 31, 2021

The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Highlights: According to a U.S. The patent.

THC 64

THC CBD Cannabinoids Research and Development 64

The Joint Blog

JANUARY 12, 2020

However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” said Cornell University veterinary researcher Joseph Wakshlag: He studies therapeutic uses for the compound.

Pets 36

Pets CBD Clinical Trials Research and Development 36

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! But CBD’s stolen the spotlight, partially because of its good cop/bad cop relationship with another famous cannabinoid: T etrahydrocannabinol or THC. THC is responsible for marijuana’s psychoactive effects. What makes CBD special?

CBD 99

CBD DEA Research and Development Hemp 99

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The drug does not contain any of the psycho-active component of cannabis, a compound called tetrahydrocannabinol (THC). What about other medical cannabis products? September 23, 2019.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., THC, or tetrahydrocannabinol, in cannabis plants has psychoactive properties, mainly responsible for causing high as it binds to the high causing receptors of the brain.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

Otherside Farms

APRIL 14, 2020

Research on CBD ( cannabidiol ) shows that it has vast therapeutic properties. The findings were confirmed by similar research conduction in the following year. The findings were confirmed by similar research conduction in the following year. In June of 2019, the FDA in the U.S. In June of 2019, the FDA in the U.S.

CBD 52

CBD Research and Development Sleep Clinical Trials 52

Alchimia

FEBRUARY 1, 2022

CBD is one of the principal cannabinoids found in cannabis and, along with THC, one of its best-known compounds. The truth is that CBD has proven to have multiple properties that are useful both in the recreational field (since it modulates the adverse effects of THC) and in the medicinal field. Drowsiness. Mild fatigue.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Severe treatment-resistant epilepsy. THC ( delta-9-tetrahydrocannabinol). a combination of cannabidiol (CBD) with THC. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. 1.4 Severe treatment-resistant epilepsy. Recommendations.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

FEBRUARY 3, 2022

Based on the compound, the market is segmented into tetrahydrocannabinol (THC)-dominant, cannabidiol (CBD)-dominant, and balanced THC and CBD. Cannabis is no longer just utilized for its tetrahydrocannabinol (THC) effects of getting high. Product Development Via Research and Novel Product Delivery Solutions.

Indica 52

Indica Oil Legalization Research and Development 52

Cannabis Law Report

DECEMBER 7, 2021

Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 12, 2019

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). This report (abstract below) asks if Epidiolex is as efficient a drug as the manufacturer believes it to be.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

APRIL 10, 2019

Just over 80 prescriptions for medical cannabis (THC and CBD) have been written, according to Hancock. “We The Government need to push for centres of excellence to help to stimulate the research they say they are calling for.”. To date, research has centred on two major cannabinoids, tetrahydrocannabinol and cannabidiol.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

SMPL

MAY 26, 2020

Mr. Laughter and Lawrence Ringo, an old-school hippie grower, were some of the first Americans to intentionally cultivate plants higher in CBD than in THC — the compound that does get you high. At the time of Samantha Miller’s summit in 2011, THC was the sole chemical “face” of the plant. San Francisco weekly.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

DECEMBER 21, 2019

Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.

Research and Development 59

Research and Development CBD Conditions Therapy 59

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. Music by Desca.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. At the same time, the outlook on cannabis research data is largely positive. Primary sources most frequently used in these reports are peer-reviewed journals or government reports, voices from medical associations or foundations, as well as government and university researchers.

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Highlights: According to a U.S. The patent.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Puff Puff Post

DECEMBER 28, 2018

Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. THC – the main molecule responsible for feeling high, stoned, or any effects associated with weed isn’t used for treatment. As it sits, only a few methods of treating autism are available.

Treatment 76

Treatment Oil CBD Therapy 76

The Cannigma

MAY 7, 2021

This is where the crux of the issue is, if you are a patient then you have epilepsy or your child has epilepsy, you want a qualified product that you can rely on that has the same level of provision in relation to the manufacturing process as any other medicine that you would take. How do we solve this climate change?”

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

OCTOBER 17, 2019

Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. So, the strains that are very popular in the rec world are almost exclusively the high THC products. They’re using cannabis because they want to get high.

Legalization 128

Legalization Patients Education Dispensary 128